Whitebox Advisors’s AEON Biopharma, Inc. Warrants, each whole warrant exercisable to purchase one share of Class A Common Stock at an exercise price of $11.50 per share AEON.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-92,000
| Closed | -$133K | – | 366 |
|
|
2024
Q1 | $133K | Hold |
92,000
| – | – | ﹤0.01% | 131 |
|
|
2023
Q4 | $9.19K | Hold |
92,000
| – | – | ﹤0.01% | 146 |
|
|
2023
Q3 | $13.8K | Hold |
92,000
| – | – | ﹤0.01% | 159 |
|
|
2023
Q2 | $8.28K | Hold |
92,000
| – | – | ﹤0.01% | 228 |
|
|
2023
Q1 | $5.06K | Hold |
92,000
| – | – | ﹤0.01% | 388 |
|
|
2022
Q4 | $4.2K | Hold |
92,000
| – | – | ﹤0.01% | 541 |
|
|
2022
Q3 | $6K | Hold |
92,000
| – | – | ﹤0.01% | 690 |
|
|
2022
Q2 | $14K | Hold |
92,000
| – | – | ﹤0.01% | 603 |
|
|
2022
Q1 | $28K | Sell |
92,000
-8,000
| -8% | -$2.44K | ﹤0.01% | 647 |
|
|
2021
Q4 | $51K | Buy |
+100,000
| New | +$51K | ﹤0.01% | 599 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 496 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 425 |
|